Replies to post #12 on Shockwave Medical Inc (SWAV)

[Whalatane]

Moro. I think below the knee with smaller devices ...due to be launched in Q4 ...is probably the next big catalyst .
Below the knee vessels usually have a high degree of calcium calcification that's risky to treat with current approach's like atherectomy's ( Rotoblator ) .

That and more use to facilitate passage of larger caths for TAVR devices etc .

The US enrollment for coronary won't be complete until Q1-Q2 in 2020 ( Recent conference quote ) with early 2021 approval .JMO
Kiwi